BVF Inc’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
GS
TCM
MAP
PM
EC
SBH
DCM
BVF Inc's LKFT Position: Q2 2025 in Review
BVF Inc sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2025, closing a stake of 1,454,422 shares — an estimated $36.5M sold.
BVF Inc first reported a position in LKFT in Q3 2019 and held it in 15 quarters. The position peaked at $88M in Q2 2023. 85 funds tracked by Wall St. Rank hold LKFT as of Q2 2025.
- BVF Inc reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2025 after selling out during the quarter.
- BVF Inc sold 1,454,422 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2025, an estimated $36.5M.
- BVF Inc first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2019 and held it in 15 quarters.
- BVF Inc's Lakefront Biotherapeutics American Depositary Shares position peaked at $88M in Q2 2023.
- 85 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2025.
Based on BVF Inc's 13F filing for Q2 2025, filed 14 Aug 2025.